VWF and melanoma: Our own in vitro studies have revealed that melanoma cells activate vascular endothelial cells (ECs), thus resulting in the exocytosis of Weibel-Palade bodies (WPBs) and the release of procoagulatory, ultra-large von Willebrand factor (ULVWF) multimers from intact ECs [13–15].